Pathogenetic role of cholecystokinin in functional dyspepsia

Introduction. The high prevalence of functional dyspepsia in the population requires detailing the mechanisms of its development with the definition of the role of hormones of the gastrointestinal tract in the development of clinical symptoms.
Purpose of the study: to clarify the pathogenetic role of cholecystokinin in functional dyspepsia.
Materials and methods. A prospective examination of 90 people aged 22.3 ± 0.17 years, divided into 3 groups, was carried out: patients with postprandial distress syndrome (PDS), patients with epigastric pain syndrome (EPS), practically healthy. The participants of the study were questioned according to the GSRS questionnaire, their anthropometric data, the concentration of cholecystokinin in the blood before and after the drinking test were determined. Statistical processing included calculation of means, their errors, Mann-Whitney U-test for independent samples and Wilcoxon W-test for related samples, Spearman’s rank correlation test.
Results. Patients with EPS are characterized by a statistically significantly greater severity of abdominal pain syndrome (4.33 ± 0.51 points) than those suffering from PDS (2.47 ± 0.38 points) and healthy people (2.19 ± 0.22 points). Dyspeptic syndrome is more typical for patients with PDS (2.07 ± 0.12 points) than those with EPS (1.10 ± 0.04 points). Patients with PDS are characterized by higher values of height, hip volume, lean mass, waist to hip ratio than patients with EPS. The concentration of cholecystokinin in the blood on an empty stomach in patients with EPS (213.37 ± 14.35 pg/ml) is statistically significantly higher than in those examined with PDS (129.45 ± 10.44 pg/ml) and healthy people (146.99 ± 5.17 pg/ml). The level of cholecystokinin in the blood after water exercise in patients with PDS increased statistically significantly to 176.14 ± 8.16 pg/ml, with EPS – decreased to 187.98 ± 7.26 pg/ml. Correlations between the magnitude of cholecystokininemia and the main anthropometric data in EPS and PDS are multidirectional.
Conclusion. Cholecystokinin plays an important role in the pathogenesis of gastroduodenal motility disorders in patients with functional dyspepsia.

1. Лазебник Л.Б., Алексеенко С.А., Лялюкова Е.А., Самсонов А.А., Бордин Д.С., Цуканов В.В. и др. Рекомендации по ведению первичных пациентов с симптомами диспепсии. Экспериментальная и клиническая гастроэнтерология. 2018;(5):4–18. Режим доступа: https://www.nogr.org/jour/article/view/605/600. Lazebnik L.B., Alekseenko S.A., Lyalyukova E.A., Samsonov A.A., Bordin D.S., Tsukanov V.V. et al. Recommendations for the management of primary patients with symptoms of dyspepsia. Experimental and Clinical Gastroenterology. 2018;(5):4–18. (In Russ.) Available at: https://www.nogr.org/jour/article/view/605/600.

2. Лазебник Л.Б., Голованова Е.В., Волель Б.А., Корочанская Н.В., Лялюкова Е.А., Мокшина М.В. и др. Функциональные заболевания органов пищеварения. Синдромы перекреста. Клинические рекомендации Российского научного медицинского общества терапевтов и Научного общества гастроэнтерологов России. Экспериментальная и клиническая гастроэнтерология. 2021;(8):5–117. https://doi.org/10.31146/1682-8658-ecg-192-8-5-117. Lazebnik L.B., Golovanova E.V., Volel B.A., Korochanskaya N.V., Lyalyukova E.A., Mokshina M.V. et al. Functional gastrointestinal disorders. Overlap syndrome Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of Russia. Experimental and Clinical Gastroenterology. 2021;(8):5–117. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-192-8-5-117.

3. Ford A.C., Marwaha A., Sood R., Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64(7):1049–1057. https://doi.org/10.1136/gutjnl-2014-307843.

4. Mahadeva S., Yadav H., Everett S.M., Goh K.L. Economic impact of dyspepsia in rural and urban Malaysia: a population-based study. J Neurogastroenterol Motil. 2012;18(1):43–57. https://doi.org/10.5056/jnm.2012.18.1.43.

5. Wauters L., Dickman R., Drug V., Mulak A., Serra J., Enck P. et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. United European Gastroenterol J. 2021;9(3):307–331. https://doi.org/10.1002/ueg2.12061.

6. Stanghellini V., Chan F.K., Hasler W.L., Malagelada J.R., Suzuki H., Tack J., Talley N.J. Gastroduodenal Disorders. Gastroenterology. 2016;150(6):1380–1392. https://doi.org/10.1053/j.gastro.2016.02.011.

7. Баранов С.А., Нечаев В.М., Шульпекова Ю.О., Супряга И.В., Курбатова А.А. Функциональная диспепсия и методы ее лечения. Научно-практическая ревматология. 2020;58(1):87–90. Режим доступа: https://rsp.mediar-press.net/rsp/article/view/2847/1933. Baranov S.A., Nechaev V.M., Shulpekova Yu.O., Supryaga I.V., Kurbatova A.A. Functional dyspepsia and its treatment methods. Rheumatology Science and Practice. 2020;58(1):87–90. (In Russ.) Available at: https://rsp.mediarpress.net/rsp/article/view/2847/1933.

8. Sperber A.D., Bangdiwala S.I., Drossman D.A., Ghoshal U.C., Simren M., Tack J. et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99–114.e3. https://doi.org/10.1053/j.gastro.2020.04.014.

9. Moayyedi P., Lacy B.E., Andrews C.N., Enns R.A., Howden C.W., Vakil N. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017;112(7):988–1013. https://doi.org/10.1038/ajg.2017.154.

10. Шкляев А.Е., Шутова А.А., Бессонов А.Г., Максимов К.В. Особенности проявлений функциональной диспепсии у студентов медицинского вуза различных лет обучения. Экспериментальная и клиническая гастроэнтерология. 2020;(9):24–28. https://doi.org/10.31146/1682-8658-ecg-181-9-24-28. Shklyaev A.E., Shutova A.A., Bessonov A.G., Maksimov K.V. Features of manifestations of functional dyspepsia in medical students of various years of study. Experimental and Clinical Gastroenterology. 2020;(9):24–28. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-181-9-24-28.

11. Simrén M., Vos R., Janssens J, Tack J. Acid infusion enhances duodenal mechanosensitivity in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2003;285(2):G309–315. https://doi.org/10.1152/ajpgi.00242.2002.

12. Talley N.J., Ford A.C. Functional Dyspepsia. N Engl J Med. 2015;373(19):1853–1863. https://doi.org/10.1056/NEJMra1501505.

13. Казарин Д.Д., Шкляев А.Е., Горбунов Ю.В. Особенности расстройств пищевого поведения у больных хроническим гастритом на фоне сахарного диабета 2 типа. Архивъ внутренней медицины. 2019;9(4):296–300. https://doi.org/10.20514/2226-6704-2019-9-4-296-300. Kazarin D.D., Shklyaev A.E., Gorbunov Yu.V. Features of eating disorders in patients with chronic gastritis on the background of type 2 diabetes mellitus. Russian Archives of Internal Medicine. 2019;9(4):296–300. (In Russ.) https://doi.org/10.20514/2226-6704-2019-9-4-296-300.

14. Шкляев А.Е., Григорьева О.А., Мерзлякова Ю.С., Максимов К.В., Казарин Д.Д. Влияние пищевого поведения, распределения жира и физической активности на симптомы функциональных гастроинтестинальных расстройств. Siberian Journal of Life Sciences and Agriculture. 2021;13(3):46–62. https://doi.org/10.12731/2658-6649-2021-13-3-46-62. Shklyaev A.E., Grigorieva O.A., Merzlyakova Yu.S., Maksimov K.V., Kazarin D.D. Influence of eating behavior, fat distribution and physical activity on symptoms of functional gastrointestinal disorders. Siberian Journal of Life Sciences and Agriculture. 2021;13(3):46–62. (In Russ.) https://doi.org/10.12731/2658-6649-2021-13-3-46-62.

15. Caldarella M.P., Azpiroz F., Malagelada J.R. Antro-fundic dysfunctions in functional dyspepsia. Gastroenterology. 2003;124(5):1220–1229. https://doi.org/10.1016/s0016-5085(03)00287-7.

16. Tack J., Piessevaux H., Coulie B., Caenepeel P., Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115(6):1346–1352. https://doi.org/10.1016/s0016-5085(98)70012-5.

17. Шкляев А.Е., Семеновых Е.А., Максимов К.В. Коррекция постпрандиального дистресс-синдрома у молодой больной курсовым применением негазированной минеральной воды «Увинская». Экспериментальная и клиническая гастроэнтерология. 2020;(9):89–93. https://doi.org/10.31146/1682-8658-ecg-181-9-89-93. Shklyaev A.E., Semenovykh E.A., Maksimov K.V. Management of postprandial distress syndrome in a young patient with the course application of still mineral water “Uvinskaya”. Experimental and Clinical Gastroenterology. 2020;(9):89–93. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-181-9-89-93.

18. Bratten J., Jones M.P. Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system. J Clin Gastroenterol. 2009;43(6):527–533. https://doi.org/10.1097/MCG.0b013e31818e37ab.

19. Шкляев А.Е., Галиханова Ю.И., Бессонов А.Г., Максимов К.В. Повышение потребления минеральной воды позволяет коррегировать психоэмоциональный статус у молодых лиц с избыточной массой тела. Экспериментальная и клиническая гастроэнтерология. 2020;(9):18–23. https://doi.org/10.31146/1682-8658-ecg-181-9-18-23. Shklyaev A.E., Galikhanova Yu.I., Bessonov A.G., Maximov K.V. The correction of psychoemotional status in young people with overweight with increased consumption of mineral water. Experimental and Clinical Gastroenterology. 2020;(9):18–23. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-181-9-18-23.

20. Riezzo G., Chimienti G., Clemente C., D’Attoma B., Orlando A., Mammone Rinaldi C., Russo F. Colonic Transit Time and Gut Peptides in Adult Patients with Slow and Normal Colonic Transit Constipation. Biomed Res Int. 2017:3178263. https://doi.org/10.1155/2017/3178263.

21. Карева Е.Н., Сереброва С.Ю. Медикаментозное лечение нарушений моторики желудка – проблемы, пути решения, достижения. Экспериментальная и клиническая гастроэнтерология. 2017;(7):167–183. Режим доступа: https://www.nogr.org/jour/article/view/469. Kareva E.N., Serebrova S.Yu. Сhallenges in drug treatment of gastric motility disorders. Experimental and Clinical Gastroenterology. 2017;(7):167–183. (In Russ.) Available at: https://www.nogr.org/jour/article/view/469.

22. Moran T.H., Chen J., Bi S. Chapter 131 – Cholecystokinin and SatietyCholecystokinin and satiety. In: Kastin A.J. (ed.). Handbook of Biologically Active Peptides. Amsterdam: Academic Press; 2006, pp. 961–968. https://doi.org/10.1016/B978-012369442-3/50134-3.

23. Марьянович А.Т., Андреевская М.В. Единый механизм пептидной регуляции мозга и кишки. Российские биомедицинские исследования. 2020;5(1):3–11. Режим доступа: https://gpmu.org/userfiles/file/journals/ Biomedical/Бiomed_1_2020_korrekt.pdf. Maryanovich A.T., Andreevskaya M.V. A single mechanism of peptide regulation of the brain and intestine. Russian Biomedical Research. 2020;5(1):3–11. (In Russ.) Available at: https://gpmu.org/userfiles/file/journals/Biomedical/Бiomed_1_2020_korrekt.pdf.

24. Немцов Л.М. Патофизиологическое и клинико-диагностическое значение холецистокинина при билиарной патологии. Вестник Витебского государственного медицинского университета. 2014;13(4):11–20. Режим доступа: http://vestnik.vsmu.by/ archive/2014/13-4/2014-4-11-20.html. Nemtsov L.M. Pathophysiological and clinical diagnostic significance of cholecystokinin in biliary pathology. Vestnik of Vitebsk State Medical University. 2014;13(4):11–20. (In Russ.) Available at: http://vestnik.vsmu.by/archive/2014/13-4/2014-4-11-20.html.

25. Chaudhri O., Small C., Bloom S. Gastrointestinal hormones regulating appetite. Philos Trans R Soc Lond B Biol Sci. 2006;361(1471):1187–1209. https://doi.org/10.1098/rstb.2006.1856.

26. Verberne A.J., Saita M., Sartor D.M. Chemical stimulation of vagal afferent neurons and sympathetic vasomotor tone. Brain Res Brain Res Rev. 2003;41(2-3):288–305. https://doi.org/10.1016/s0165-0173(02)00269-2.

27. Буеверов А.О. Недооцененная сила. Плацебо и ноцебо в медицине. Медицинский совет. 2020;(4):162–167. https://doi.org/10.21518/2079-701X-2020-4-162-167. Bueverov A.O. Underappreciated power. Placebo and nocebo in medicine. Meditsinskiy Sovet. 2020;(4):162–167. (In Russ.) https://doi.org/10.21518/2079- 701X-2020-4-162-167.

28. Madisch A., Andresen V., Enck P., Labenz J., Frieling T., Schemann M. The Diagnosis and Treatment of Functional Dyspepsia. Dtsch Arztebl Int. 2018;115(13):222–232. https://doi.org/10.3238/arztebl.2018.0222.

29. Sirchak Y.S., Stan M.P., Brych V.V. Changes in cholecystokinin level in patients with gastroesophageal reflux disease on the background of type II diabetes. Wiad Lek. 2018;71(2-1):333–336. Available at: https://pubmed.ncbi.nlm.nih.gov/29729168/.

30. Van Boxel O.S., ter Linde J.J., Oors J., Otto B., Feinle-Bisset C., Smout A.J., Siersema P.D. Duodenal lipid-induced symptom generation in gastroesophageal reflux disease: role of apolipoprotein A-IV and cholecystokinin. Neurogastroenterol Motil. 2012;24(4):350–e168. https://doi.org/10.1111/j.1365-2982.2012.01880.x.

31. Biberoglu E., Kirbas A., Iskender C., Dirican A., Daglar H., Demirtas C. et al. Disturbed release of cholecystokinin in pregnant women with hyperemesis gravidarum. J Obstet Gynaecol Res. 2015;41(4):505–511. https://doi.org/10.1111/jog.12562.

32. Шкляев А.Е., Горбунов Ю.В. Применение специфического и неспецифического опросников для оценки качества жизни пациентов с функциональной патологией кишечника. Архивъ внутренней медицины. 2016;6(4):53–57. https://doi.org/10.20514/2226-6704-2016-6-4-53-57. Shklyaev A.E., Gorbunov Yu.V. Application of specific and non-specific questionnaires to assess the quality of life of patients with functional bowel pathology. Russian Archives of Internal Medicine. 2016;6(4):53–57. (In Russ.) https://doi.org/10.20514/2226-6704-2016-6-4-53-57.

33. Шкляев А.Е., Бендерская Е.Ю., Максимов К.В., Гасанов А.М. Аккомодация желудка: влияние антропометрических факторов. Современные проблемы науки и образования. 2017;(5). Режим доступа: https://scienceeducation.ru/ru/article/view?id=26790. Shklyaev A.E., Benderskaya E.Yu., Maksimov K.V., Gasanov A.M. Accommodation of the stomach: the influence of anthropometric factors. Modern Problems of Science and Education. 2017;(5). (In Russ.) Available at: https://science-education.ru/ru/article/view?id=26790.

34. El-Omar E., Penman I., Ardill J.E., McColl K.E. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut. 1995;36(4):534–538. https://doi. org/10.1136/gut.36.4.534.

35. Варванина Г.Г., Винокурова Л.В., Агафонов М.А., Ткаченко Е.В., Дубцова Е.А. Роль гастроинтестинальных гормонов в регуляции панкреатической секреции. Consilium Medicum. 2014;16(8):83–85. Режим доступа: https://consilium.orscience.ru/2075-1753/article/view/94171. Varvanina G.G., Vinokurova L.V., Agafonov M.A., Tkachenko E.V., Dubtsova E.A. The role of gastrointestinal hormones in the regulation of pancreatic secretion. Consilium Medicum. 2014;16(8):83–85. (In Russ.) Available at: https://consilium.orscience.ru/2075-1753/article/view/94171.